Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Ceccarelli

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Nature Cancer|March 8, 2021
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesLuciano Garofano, Simona Migliozzi, Young Taek Oh, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 18, 2022
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapyAndrea Anichini, Alessandra Molla, Gabriella Nicolini, et al.
Journal for Immunotherapy of Cancer|May 8, 2020
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune responseJessica Roelands, Wouter Hendrickx, Gabriele Zoppoli, et al.
Molecular Therapy. Nucleic Acids|March 1, 2024
MiR-449a antagonizes EMT through IL-6-mediated <i>trans</i>-signaling in laryngeal squamous cancerAlessia Maria Cossu, Federica Melisi, Teresa Maria Rosaria Noviello, et al.
Science (New York, N.Y.)|July 28, 2012
Transforming fusions of FGFR and TACC genes in human glioblastomaDevendra Singh, Joseph Minhow Chan, Pietro Zoppoli, et al.
Cell Reports. Medicine|June 25, 2025
Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecanNicolas Huyghe, Elena Benidovskaya, Tariq Masoodi, et al.
Journal of Translational Medicine|October 22, 2025
Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppressionMylan R Blomquist, Teresa M R Noviello, Christopher Sereduk, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapyErika Ciervo, Francesco Ceccarelli, Anna Maria Di Giacomo, et al.
Communications Medicine|May 7, 2026
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanomaElena Splendiani, Zein Mersini Besharat, Claudia Sabato, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
γ-aminobutyric acid receptor B signaling drives glioblastoma in females in an immune-dependent mannerAsmita Pathak, Sravya Palasalava, Maxon V Knott, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Nature Cancer|March 8, 2021
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesLuciano Garofano, Simona Migliozzi, Young Taek Oh, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 18, 2022
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapyAndrea Anichini, Alessandra Molla, Gabriella Nicolini, et al.
Journal for Immunotherapy of Cancer|May 8, 2020
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune responseJessica Roelands, Wouter Hendrickx, Gabriele Zoppoli, et al.
Molecular Therapy. Nucleic Acids|March 1, 2024
MiR-449a antagonizes EMT through IL-6-mediated <i>trans</i>-signaling in laryngeal squamous cancerAlessia Maria Cossu, Federica Melisi, Teresa Maria Rosaria Noviello, et al.
Science (New York, N.Y.)|July 28, 2012
Transforming fusions of FGFR and TACC genes in human glioblastomaDevendra Singh, Joseph Minhow Chan, Pietro Zoppoli, et al.
Cell Reports. Medicine|June 25, 2025
Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecanNicolas Huyghe, Elena Benidovskaya, Tariq Masoodi, et al.
Journal of Translational Medicine|October 22, 2025
Glioblastoma resistance to EGFR antibody-drug conjugate is driven by transcriptional reprogramming and TEK-induced EGFR suppressionMylan R Blomquist, Teresa M R Noviello, Christopher Sereduk, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapyErika Ciervo, Francesco Ceccarelli, Anna Maria Di Giacomo, et al.
Communications Medicine|May 7, 2026
Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanomaElena Splendiani, Zein Mersini Besharat, Claudia Sabato, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
γ-aminobutyric acid receptor B signaling drives glioblastoma in females in an immune-dependent mannerAsmita Pathak, Sravya Palasalava, Maxon V Knott, et al.
Pageof 15